December 9, 2024By Matt Fates, Partner, and Eon Mattis, Associate Discovering Next-Generation Materials is Crucial, Yet Complicated For centuries, alloys like steel,…
July 19, 2024Summary A brand is often a company's most valuable asset. Consider Nike's Swoosh or McDonald's Golden Arches. While trademarking is…
May 23, 2024By Matt Fates, Partner, and Jeff Knox, Associate Summary The world has grand ambitions to build much of tomorrow’s materials…
January 11, 2024By Matt Fates, Partner and Jeff Knox, Associate Summary The last two decades have seen tremendous expansion of biological…
August 8, 2023Summary In drug development, new molecular entities get all the press. That’s largely justified – new molecules mean new medicines…
June 14, 2023Even before Generative AI caught fire, computationally aided drug discovery was an area of intense interest for researchers. It should…
April 11, 2023By Mark Legare, Senior Associate at Innospark Ventures Certain industries match well with certain founder profiles. A statement as equally…
September 21, 2022By Matt Fates, Partner at Innospark Ventures At any given time, there are roughly 400,000 clinical trials occurring globally. In…
July 7, 2022As skilled and advanced as the $2T pharma industry is in many regards, there are still key areas where it…
